Differential effects of antibodies to vascular cell adhesion molecule-1 and distinct epitopes of the α4 integrin in HgCl2-induced nephritis in brown Norway rats

Journal of the American Society of Nephrology

Volumn 9, Issue 10, 1998, Pages 1881-1891

  Escudero, Esther ^a   Nieto, Marta ^b   Martín, Ana ^a   Molina, Ana ^a   Lobb, Roy R ^c   Sanchez Madrid, Francisco ^b   Mampaso, Francisco ^a,d  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c BIOGEN   (United States)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; MERCURY CHLORIDE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CELL INTERACTION; CONTROLLED STUDY; CROSS REACTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; EXTRAVASATION; LEUKOCYTE MIGRATION; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031687269     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314, 1994
2. Jutila MA: Leukocyte traffic to sites of inflammation. APMIS 100: 191-201, 1992
3. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101, 1994
4. Cronstein BN, Weissmann G: The adhesion molecules in inflammation. Arthritis Rheum 36: 147-157, 1993
5. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25, 1992
6. Postigo AA, Sanchez-Madrid F: Adhesion and homing molecules. Transplant Proc 25: 65-69, 1993
7. Postigo A, Teixidó J, Sanchez-Madrid F: The alpha 4 beta 1/VCAM-1 adhesion pathway in physiology and disease. Res Immunol 144: 723-735, 1993
8. Lobb RR, Hemler ME: The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest 94: 1722-1728, 1994
9. Berlin C, Bargatze RF, Campbell JJ, von Adrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC: Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80: 413-422, 1995
10. Hemler ME, Huang C, Takada Y, Schwarz L, Strominger JL, Clabby ML: Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem 262: 11478-11485, 1987
11. Wayner EA, García-Pardo A, Humphries MJ, MacDonald JA, Carter WG: Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1). J Cell Biol 109: 1321-1330, 1989
12. Mould AP, Komoriya A, Yamada KM, Humphries MJ: The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1: Inhibition of alpha 4 beta 1 function by RGD peptide homologues. J Biol Chem 266: 3576-3585, 1991
13. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyi S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577-584, 1990
14. Rice GE, Bevilacqua MP: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303-1306, 1989
15. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyi S, Chi-Rosso G, Lobb RR: Direct expression cloning of vascular cell adhesion molecule-1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59: 1203-1211, 1989
16. Pober JS, Cotran RS: What can be learned from the expression of endothelial adhesion molecules in tissues? [Editorial] Lab Invest 64: 301-305, 1991
17. Hemler ME, Elices MJ, Parker C, Takada Y: Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 114: 45-65, 1990
18. Clayberger C, Krensky AM, McIntyre BW, Koller TS, Parham P, Brodsky F, Linn DJ, Evans EL: Identification and characterization of two novel lymphocyte function-associated antigens, L24 and L25. J Immunol 138: 1510-1514, 1987
19. Campanero MR, Pulido R, Ursa MA, Rodriguez-Moya M, de Landázuri MO, Sanchez-Madrid F: An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1-independent, triggered through the human VLA-4 integrin. J Cell Biol 110: 2157-2165, 1990
20. Bednarczyk JL, McIntyre BW: A monoclonal antibody to VLA-4a chain (CDw49d) induces homotypic lymphocyte aggregation. J Immunol 144: 777-784, 1990
21. Pulido R, Campanero MR, García-Pardo A, Sanchez-Madrid F: Structure-function analysis of the human integrin VLA-4 (alpha 4/beta 1): Correlation of proteolytic alpha 4 peptides with alpha 4 epitopes and sites of ligand interaction. FEBS Lett 294: 121-124, 1991
22. Pulido R, Elices MJ, Campanero MR, Osborn LS, Schiffer S, García-Pardo A, Lobb RR, Hemler ME, Sanchez-Madrid F: Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4: Correlation with distinct alpha 4 epitopes. J Biol Chem 266: 10241-10245, 1991
23. Schiffer S, Hemler ME, Lobb RR, Tizard R, Osborn L: Molecular mapping of functional antibody binding sites of alpha 4 integrin. J Biol Chem 270: 14270-14273, 1995
24. Kamata T, Puzon W, Takada Y: Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, cd49d/CD29). Biochem J 305: 945-951, 1995
25. Issekutz TB: Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody: A likely role of VLA-4 in vivo. J Immunol 147: 4178-4184, 1991
26. Rabb H, Martin JG: An emerging paradigm shift on the role of leukocyte adhesion molecules. J Clin Invest 100: 2937-2938, 1997
27. Wahl SM, Allen JB, Hines KL, Imamichi T, Wahl AM, Furch LT, MacCarthy JB: Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 94: 655-662, 1994
28. Orosz CG, van Buskirk A, Sedmak DD, Kincade P, Miyake K, Pelletier RP: Role of the endothelial adhesion molecule VCAM in murine cardiac allograft rejection. Immunol Lett 32: 7-12, 1992
29. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N: Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356: 63-66, 1992
30. Sanchez-Madrid F, Landázuri MO, Morago G, Cebrian M, Acevedo A, Bernabeu C: VLA-3: A novel polypeptide association within the VLA molecular complex: Cell distribution and biochemical characterization. Eur J Immunol 16: 1343-1349, 1986
31. May MJ, Entwistle G, Humphries MJ, Ager A: VCAM-1 is a CS-1 peptide-inhibitable adhesion molecule expressed by lymph node high endothelium. J Cell Sci 106: 109-119, 1993
32. Lemstron K, Koskinen P, Hayry P: Induction of adhesion molecules on the endothelia of rejecting cardiac allografts. J Heart Lung Transplant 14: 205-213, 1995
33. Bell EB, Sparsholt SM, Ager A: Migration pathways of CD4 T cell subsets in vivo: The CD45RC-subset enters the thymus via alpha 4 integrin-VCAM-1 interaction. Int Immunol 7: 1861-1871, 1995
34. Eddy AA, Crary GS, Michael AF: Identification of lymphohemopoietic cells in the kidneys of normal rats. Am J Pathol 129: 335-342, 1986
35. Barnstable CJ, Bodurer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A: Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: New tools for genetics analysis. Cell 14: 9-18, 1978
36. Bowman C, Mason DW, Pusey CD, Lockwood CM: Autoregulation of autoantibody synthesis in mercuric chloride nephritis in the Brown Norway rat: A role for the T suppressor cells. Eur J Immunol 14: 464-470, 1984
37. Molina A, Sanchez-Madrid F, Bricio T, Martin A, Escudero E, Alvarez V, Mampaso F: Abrogation of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against TNFα. Mediators Inflammation 4: 444-454, 1995
38. Molina A, Sanchez-Madrid F, Bricio T, Martín A, Barat A, Alvarez V, Mampaso F: Prevention of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against the α4 integrin. J Immunol 153: 2313-2320, 1994
39. Bricio T, Mampaso F: Natural killer function in the rat with interstitial nephritis. Scand J Immunol 33: 639-645, 1991
40. Arroyo AG, Sánchez-Mateos P, Campanero MR, Martín-Padura I, Dejana E, Sanchez-Madrid F: Regulation of the VLA-4 integrin-ligand interactions through the β1 subunit. J Cell Biol 177: 659-670, 1992
41. Bowman C, Peters DK, Lockwood CM: Anti-glomerular basement membrane autoantibodies in the Brown Norway rat: Detection by a solid-phase radioimmunoassay. J Immunol Methods 61: 325-333, 1983
42. Mampaso FM, Egido J, Martínez-Montero JC, Bricio T, González E, Pirotzky E, Braquet P, Hernando L: Interstitial mononuclear cell infiltrates in experimental nephrosis: Effect of PAF antagonist. Nephrol Dial Transplant 4: 1037-1044, 1989
43. Gimenez A, Mampaso M: Characterization of inflammatory cells in drug-induced tubulointerstitial nephritis. Nephron 43: 239-240, 1986
44. Mampaso FM, Wilson CB: Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats. Kidney Int 23: 448-457, 1983
45. Issekutz TB: Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity. Am J Pathol 143: 1286-1293, 1993
46. Weg VB, Williams TJ, Lobb RR, Nourshargh S: A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 177: 561-566, 1993
47. Paul LC, Davidoff A, Benediktsson H, Issekutz TB: The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplantation (Baltimore) 55: 1196-1199, 1993
48. Mulligan MS, Johnson KJ, Todd RF, Issekutz TB, Miyasaka M, Tamatani T, Swith CW, Anderson DC, Ward PA: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91: 577-587, 1993
49. Abraham WM, Sielczak MW, Ahmed A, Cortes A, Lauredo IT, Kim J, Pepinsky B, Benjamin CD, Leone DR, Lobb RR, Weller PF: α4 integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 93: 776-787, 1994
50. Rabb H, Olivenstein R, Issekutz TB, Renzi PM, Martin JG, Pantano R, Seguin S: The role of the leukocyte adhesion molecules VLA-4, LFA-1, and MAC-1 in allergic airway responses in the rat. Am J Respir Crit Care Med 149: 1186-1191, 1994
51. Petrolani M, Ruffle C, Lapa JR, Joseph D, Lobb R, Vargaftig B: Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 180: 795-805, 1994
52. Sapin C, Druet E, Druet P: Induction of anti-glomerular basement membrane antibodies in the Brown Norway rat by mercuric chloride. Clin Exp Immunol 28: 173-179, 1977
53. Pelletier L, Pasquier R, Rossert J, Vial MC, Mandet C, Druet P: Autoreactive T cells in mercury-induced autoimmunity: Ability to induce the autoimmune disease. J Immunol 140: 750-754, 1988
54. Altevogt P, Hubbe M, Ruppert M, Lohr J, von Hoegen P, Sammar M, Andrew DP, McEvoy L, Humphries MJ, Butcher EC: The alpha 4 chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1. J Exp Med 182: 345-355, 1995
55. Muñoz M, Serrador J, Sanchez-Madrid F, Teixido J: A region of the integrin VLA alpha 4 subunit involved in homotypic cell aggregation and fibronectin but not vascular cell adhesion molecule-1 binding. J Biol Chem 271: 2696-2702, 1995
56. Elices MJ, Tsai V, Strahl D, Goel AS, Tolefson V, Arrhenius T, Wayner EA, Gaeta FCA, Firestein GS: Expression and functional significance of alternatively spliced CS-1 fibronectin in rheumatoid microvasculature. J Clin Invest 93: 405-412, 1994
57. Rabb H, Rosen R, Ramirez G: VLA-4 and its ligands: Relevance to kidney diseases. Springer Semin Immunopathol 16: 417-425, 1995